Advances supporting IVT mRNA medicines

In this application note from GenScript, explore the outcomes of the scientific symposium ‘Therapeutic Applications of Non-Viral RNA: Therapy Strategies’ at the American Society of Gene & Cell Therapy (ASGCT) 2022 annual meeting. The symposium featured investigators from the University of Pennsylvania and Moderna Therapeutics who provided deep insight on the advantages of RNA technology for drug development. Furthermore, discover an overview of IVT mRNA structural and delivery advances enabling today’s therapies and mRNA therapy modalities advancing through clinical trials.